Jason Wellen

Medicine & Life Sciences

1. Tissue Donors 100%
2. Transplants 83%
3. Kidney Transplantation 80%
4. Liver Transplantation 73%
5. Kidney 46%
6. Living Donors 37%
7. Tissue and Organ Procurement 37%
8. Allografts 30%
9. Pancreas 29%
10. Pancreas Transplantation 27%
11. Transplant Recipients 27%
12. Graft Survival 27%
13. Autoantigens 21%
14. Survival 19%
15. Transplantation 16%
16. Nephrectomy 15%
17. Antibodies 14%
18. Operating Rooms 14%
19. Organ Transplantation 14%
20. Cohort Studies 14%
21. Costs and Cost Analysis 13%
22. Everolimus 13%
23. Morbid Obesity 12%
24. Robotics 12%
25. Body Mass Index 11%
26. Hepatitis C 11%
27. TOR Serine-Threonine Kinases 11%
28. Hepacivirus 11%
29. Pediatrics 11%
30. Organizations 10%
31. Delayed Graft Function 10%
32. Antiviral Agents 10%
33. Liver 9%
34. Type 1 Diabetes Mellitus 9%
35. HLA Antigens 9%
36. Incisional Hernia 8%
37. Calcineurin Inhibitors 8%
38. Taxes 8%
39. Hepatocellular Carcinoma 8%
40. End Stage Liver Disease 8%
41. Fibronectins 8%
42. Biopsy 7%
43. Retrospective Studies 7%
44. Collagen 7%
45. Learning Curve 7%
46. Immunoglobulin Class Switching 7%
47. Hepatitis B Antibodies 6%
48. Common Hepatic Duct 6%
49. Warm Ischemia 6%
50. Psychology Rejection 6%